Outcome of Board Meeting

BAJAIJ Ref: BHL/ STEX 18/ 2026-27 Date: July 20, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5 Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex Bandra (East) Mumbai — 400001 Mumbai-400051 Scrip Code: 539872 Symbol: BAJAJHCARE Sub: Outcome of the Board Meeting held on July 20, 2026 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("Listing Regulations”) we hereby inform you that the Board of Directors of our Company at its meeting held today i.e. July 20, 2026, has considered and approved the followings: 1. Un-audited Standalone Financial Results of the Company for the quarter ended June 30, 2026 along with the Limited Review Report thereon issued by Walker Chandiok & Co LLP, Chartered Accountants, Statutory Auditors of the Company in accordance with the Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 is attached herewith as ‘Annexure A’. 2. Continuation of directorship of Mr. Gopalakrishnan Kesavan (DIN: 02105656) as a Non- Executive Independent Director of the Company upon attaining the age of 75 years. Mr. Gopalakrishnan Kesavan is not debarred from holding the office of Director by virtue of any order passed by the Securities and Exchange Board of India or any other such authority in accordance with BSE Circular No. LIST/COMP/14/2018-19 and NSE Circular No. NSE/CML/2018/24 dated 20" June 2018. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 are given in ‘Annexure B’. We wish to inform you that the Board Meeting commenced today at 5.00 p.m. and concluded at 5.31 p.m. Kindly take the same on record. Thanking you. Yours faithfully, For and on behalf of Bajaj Healthcare Limited MONICA etz TANWAR Dsieerse Monica Tanwar Company Secretary & Compliance Officer Encl: as above BAJAJ HEALTHCARE LTD Registered Office : 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39/A, B-39 A/, Road No. 23, Wagle Ind. Estate, Thane(West), Thane-400 604. © Tel.: + 9122 6617 7400 - 499 * Fax : + 91 22 66177458« Website : www bajajhealth.com CIN No.: L99998MH1993PLC072892 Annexure A Walker Chandiok & Co LLP Walker Chandiok & Co LLP 42nd Floor, Building Commerz Iil, International Business Park, Oberoi Garden City, Off Western Express Highway, Goregaon (East), Mumbai-400063 T +91 22 6626 2699 Independent Auditor's Review Report on Unaudited Quarterly Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Bajaj Healthcare Limited 1. We have reviewed the accompanying statement of unaudited financial results (‘the Statement’) of Bajaj Healthcare Limited (‘the Company’) for the quarter ended 30 June 2026, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (‘Listing Regulations'). 2. The Statement, which is the responsibility of the Company’s management and approved by the Company'’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (Ind AS 34'), prescribed under section 133 of the Companies Act, 2013 (‘the Act'), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Chartered Accountants Walker Chandiok & Co LLP is registered wilh mited liabilty wilh identification Offces in Abmedzbad, Bengaunu, Bhubaneswar, Chandigarh, Chenna, Defvadun, Goa, Gurugeam, Guwahat, Hyderabsd, Indore, numbor AAC-2085 and has is registered Jaipu, Kchi,Kolata, Mumba, New Del, Noida and Pune affica at L-41, Connaught Circus, Outer Circlo, Now Delhi, 110001, India Bajaj Healthcare Limited Independent Auditor's Review Report on Unaudited Quarterly Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) 4. Based on our review conducted as above nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirements of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Walker Chandiok & Co LLP Chartered Accountants Firm Registration No: 001076N/N500013 Yashwant M. Jain Partner Membership No. 118782 UDIN:- 26118782CFTTGV7098 Place: Mumbai Date: 20 July 2026 Chartered Accourtants Welker Chendiok & Co LLP is registerod wilh limilod Tiabity with idenificalion number Officesin Abmedabad, Bengaluru, Bhubaneswar, Chandigah, Chenna, Defvadun, Goa, Gurugram, Guvahat, Hyderabad,Indoro, AAC-2085 and has s registered ffice at L- Jaipur, Kochi, Kokata Mumbai, Now Delh, Noida and Pune 41, Connaught Circus, Outer Circle, New Delhi, 110001, India BAJAJ HEALTHCARE LIMITED (CIN No.: L99999MH1993PLC072892) (Reg. and Corp. Office: 602-608, 6th Floor, Bhoomi Velocity Infotech Park, Above ICICI Bank, Road No. 23, Wagle Industrial Estate, Thane (W) - 400 604 (Tel: +91-22-6617400, Email: investors@bajajhealth.com, Website: www.bajajhealth.com) STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED ON 30 JUNE 2026 {Rs. In Lakhs except for Earnings Per Share) Particulars Quarter Ended Year Ended 30 June 2026 | 31 March 2026] 30 June 2025 | 31 March 2026 (Unaudited) | (Refer Note 2) | (Unaudited) (Audited) A. Continuing operations 1. Revfreom onperuatieons 16,563.17 1530575 14,883.63 61,103.14 II. Other income 81.14 295.62 87.77 713.39 11l. Totalincome (I+11) 16,644.31 15,601.37 | 14,971.40 61,816.53 IV. Expenses (a) Cost of materials consumed 9,158.91 9,210.06 6,988.49 30,619.95 (b) Changes in inventories of finished goods and work-in-progress (549.24) (1,059.01) 1,070.31 1,019.54 (c) Employee benefits expense 1,747.12 1,630.11 1,435.62 6,275.26 (d) Finance costs 609.10 556.58 522,57 2,223.37 (e) Depreciation and amortisation expense. 701.38 762.87 563.65 2,754.84 (f) Other expenses 3,331.21 3,256.98 2,938.25 12,706.61 Total expenses 14,998.48 14,357.59 | 13,518.89 56,699.57 V. Profit before exceptional items and tax expense 1,645.83 1,243.78 1,452.51 6,216.96 VI Exceptionalitems (Refer Note 5 - (3,324.66) - (3,324.66) VIL. Profit/ (loss) before tax 1,645.83 (2,080.88) 1,452.51 2,892.30 VIll. Tax expense (a) Current tax - - - - (b) Deferred tax 256.55 (139.60) 235.14 761.26 Total tax expense 256.55 (139.60) 235.14 761.26 IX. Profit/ ( [Showing first 8,000 characters — download PDF for full document]